Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTG ointment vs NTG ointment + papaverine to prevent flap necrosis in immediate prepectoral breast reconstruction
KCT0011437Phase 4Not yet recruiting
- Sponsor
- L&C BIO
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in breast neoplasia and Skin Flap Necrosis comparing Nitroglycerin ointment alone with Nitroglycerin ointment plus papaverine injection (2 arms). Planned start Mar 2026; status: not yet recruiting.
02
Drugs
nitroglycerinpapaverine
03
Conditions
breast neoplasiaSkin Flap Necrosis
Beyond the preview
Go deeper on KCT0011437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011437.